Science Market Update

Biomedical News: Charlie’s Law Opens Opportunities for Stem Cell Treatments in Texas

Posted by Rebecca Inch-Partridge on Thu, Nov 02, 2017

In June, the Texas legislature unanimously passed Charlie’s Law which allows patients with chronic and terminal diseases access to experimental stem cell interventions. The law, named after the late Texas State representative Charlie Howard, is the first of its kind in the U.S.

Read More

Tags: Stem cell research, Human Stem Cell, Texas Medical Center, Biomedical Reearch, TAMU, tmc, Biotechnology Vendor Fair, Texas A&M Research, Texas A&M Life Science Funding, biotech vendor show, Texas A&M, Research equipment, laboratory suppliers, BioResearch Product Faire, pollution

$8 M in Research Funding to Expand Stem Cell Trials at UC Davis

Posted by Rebecca Inch-Partridge on Mon, Oct 16, 2017

UC Davis has a long history of ground breaking stem cell research. Possible therapies studied range from advanced wound healing, treating HIV, and reduced vision loss to the regeneration of bone in otherwise non-healing fractures. Now The California Institute for Regenerative Medicine (CIRM) has awarded UC Davis Medical Center scientists nearly $8 million in research funding to launch a special clinical trials program in Sacramento. The goal of the grant is to accelerate the development and delivery of stem cell therapies in human patients.

Read More

Tags: CA, Current Biotechnology Events, immunotherapy, Stem cell research, Human Stem Cell, California, Research Funding, laboratory equipment, research grant, laboratory equipment suppliers, UC Davis - Medical Center, Southwest Region, new research grant, UCD, Lab Supply, BioResearch Product Faire, Bioresearch Grant, Laboratory product sales, laboratory tools

UCLA: Utilizing Patient's Own Cells for Individualized Stem Cell Therapies

Posted by Rebecca Partridge on Wed, Feb 08, 2017

Researchers at UCLA believe using the patient’s own cells to create stem cells for therapeutic purposes is the future of medicine. A recently published study by scientists at UCLA demonstrates how specialized proteins change the cellular characteristics of skin cells to create induced pluripotent stem cells. These stem cells have the ability to turn into any cell type within the body. Also at UCLA, a clinical trial which uses the baby’s own blood-forming stem cells to treat the immune deficiency condition ADA-SCID, better known as “bubble baby disease,” was recently awarded a $20M grant from the California Institute for Regenerative Medicine.

Read More

Tags: University of California Los Angeles, Stem cell research, Human Stem Cell, UCLA, Stem Cell, biotech vendor show, Biotechnology trade show

Human Stem Cell Mechanisms Better Understood by UNC Chapel Hill Study

Posted by Jennifer Nieuwkerk on Tue, Apr 09, 2013

Read More

Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Human Stem Cell, Southern, BioResearch Product Faire Event, Research Funding, Stem Cell, Front Line event, NIH, NC, Front Line, laboratory equipment, Chapel Hill, NSF, UNC, laboratory equipment sales, UNC-Chapel Hill

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News